Background: Calcium intake may reduce risk of colorectal cancer, but the mechanisms remain unclear. Studies of interaction between calcium intake and SNPs in calcium-related pathways have yielded inconsistent results.
Introduction
Observational studies suggest that higher calcium intake may reduce risk of colorectal cancer (1, 2) ; however, the underlying mechanisms remain unclear (2) . Gene-environment interaction (GxE) analysis can provide insight into disease pathways (3, 4) . Studies of gene-calcium interactions for colorectal cancer have focused on SNPs in calciumrelated pathways with limited success (5, 6) . 1 The availability of genome-wide SNP data (7) now enables hypothesis-free GxE searches. This method recently identified a novel gene-processed meat interaction for colorectal cancer (3)-highlighting the potential of this approach to provide clues into disease etiology. Here, we tested interactions between approximately 2.7 million SNPs across the genome and calcium intake in 9,006 colorectal cancer cases and 9,503 controls.
Materials and Methods
We included 9,006 individuals with confirmed colorectal adenocarcinomas and 9,503 controls from the Colon Cancer Family Registry (CCFR) and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO; refs. 3, 4, 7). We excluded participants missing all genotype or calcium data, or those of non-European ancestry. Participants gave informed written consent and studies were approved by their respective Institutional Review Boards.
Genotyping, quality control, and imputation procedures have been described previously (4, 7) . Imputation to HapMap CEU was conducted using IMPUTE, BEAGLE, or MACH. In each study, SNPs were restricted on the basis of MAF>20/# samples and imputation accuracy (Rsq > 0.3). We tested approximately 2.7 million SNPs.
Data collection/harmonization procedures have been described previously (3, 4) . Calcium intake at the reference time was assessed using food frequency questionnaires (FFQ) or diet history (DALS); intake (mg/d) was determined from calcium in foods (i.e., dietary) or supplements (single þ multivitamins þ antacids) when available. Total intake was calculated as dietary þ supplemental calcium. For studies that entered supplement data as regular-versus nonuser (CCFR, OFCCR, and PMH-CCFR), regular use was assigned generic doses (1) of 500 mg/d, 500 mg/single pill, or 130 mg/multivitamin pill.
Multivariable logistic regression was used to estimate study-specific ORs and 95% confidence intervals (CI) for the association between calcium and colorectal cancer risk; study-specific estimates were combined using fixed-effects meta-analysis. We tested multiplicative GxE in each study using SNPxcalcium interaction terms, adjusting for age, sex, study center, total energy consumption, first 3 principal components of genetic ancestry, and SNP and calcium main effects. This was followed by meta-analysis across studies. Statistical significance was determined using the Figure 1 . Association between calcium intake and risk of colorectal cancer. Odds ratios (ORs) and 95% confidence intervals correspond to each quartile increase in A) total calcium intake (mg/d), B) dietary calcium intake (mg/d), and C) supplemental calcium intake (!500 versus <500 mg/d). Total and dietary calcium intake were coded as sex-and study-specific quartiles based on cutoff points in controls, and modeled as an ordinal variable. Estimates adjusted for age (continuous), sex (F/M), study center (indicators), and energy consumption (continuous). CC, case-control; lower/upper, lower and upper bounds of 95% CI. Corresponds to each additional copy of the minor allele (i.e., assuming additive genetic effects) and each quartile increase in calcium intake (total, dietary) or Research.
on June 20, 2017. © 2014 American Association for Cancer cebp.aacrjournals.org Downloaded from conventional genome-wide two-sided a ¼ 5EÀ08 (3, 7) . Heterogeneity was assessed using the Woolf test. We further explored interactions using the potentially more powerful Cocktail method (3). Statistical analyses used R, Version 2.15.1 or SAS, Version 9.3; power was estimated using Quanto, Version 1.2.4 (biostats.usc.edu/software).
Results
Higher total calcium intake was associated with reduced colorectal cancer risk (OR per quartile, 0.87; 95% CI, 0.84-0.89; Fig. 1A ). Dietary and supplemental calcium were similarly associated with reduced risk (Fig. 1B and C) . Total calcium results were similar after excluding studies that entered calcium data from only diet (DALS, DACHS, and PHS) or supplements (CCFR, OFCCR, and PMH-CCFR) (OR, 0.88; 95% CI, 0.84-0.92). Estimates were unchanged for right-versus left-sided cancers (data not shown). Supporting the validity of our calcium data, 2q21.3/MCM6/rs4988235 aka 13910 T>C, a marker of preserved lactase levels used in genetic tests of lactose intolerance (8), was associated with dietary (P ¼ 1.1EÀ13), but not supplemental (P ¼ 5.2EÀ01), intake.
There were no statistically significant SNP interactions with total, dietary, or supplemental calcium intake for colorectal cancer risk ( Table 1) . The strongest evidence of interaction was between 4q34.3/rs1028166 and supplemental calcium intake (OR interaction, 1.49; 95% CI, 1.27-1.74; P interaction ¼ 7.3EÀ07). However, rs1028166 was located 669 kb from the nearest protein-coding gene (TENM3) and showed little evidence of interaction with total or dietary intake. The Cocktail approach (3) did not identify statistically significant interactions (data not shown).
Discussion
In this large study, there were no statistically significant SNP interactions with total, dietary, or supplemental calcium intake. Candidate-gene studies of interaction between SNPs in calcium-related genes (e.g., CASR, VDR) and calcium intake have not reported consistent interactions (5, 6). Figueiredo and colleagues (9) investigated genome-wide SNP-calcium interactions for microsatellite-stable/microsatellite-instability low colorectal cancer. Consistent with our findings, they reported no statistically significant interactions in 1,191 cases and 990 controls.
Strengths of this study include the large sample size, comprehensive genetic data, and harmonization of calcium intake across 13 studies. However, misclassification of calcium intake may have attenuated associations, although calcium assessed by FFQ is reasonably accurate compared with diet records/24-hour recalls [correlations ¼ 0.48-0.70 (ref. 1)], and we detected colorectal cancer associations with magnitudes comparable with previous studies (1, 2). For total calcium quartiles, at a ¼ 5EÀ08, our study had >80% power to detect interaction ORs ! 1.33, 1.23, and 1.17 for SNPs with MAFs of 0.05, 0.10, and 0.20, respectively. We thus had adequate statistical power to detect modest interactions with common variants.
In summary, we did not observe evidence of SNP interactions with calcium intake. This suggests that individual common genetic variants do not strongly modify the association between calcium and colorectal cancer risk in European populations. Large studies with sequence data are needed to investigate interactions involving rare variants.
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